A study reveals chronic sinusitis may increase rheumatic disease risk by 40%, especially 5-10 years before symptoms. Sinusitis inflames nasal passages, obstructs mucus flow, and hampers breathing. The ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

Chronic sinusitis is a condition where inflammation and infection in your sinuses persists for extended periods of time without relief. Your sinuses work as a filter, creating mucus that drains ...

Sinusitis is a condition that occurs when sinuses become inflamed due to infections Read this article to know what might be ...

Acute sinusitis lasts a short time, while chronic sinusitis persists for more than 12 weeks. Common causes include respiratory infections, nasal polyps, or a deviated septum. In addition to ...

Multiple organisms have been isolated from infected sinuses. However, it is important to note that "normal flora" has been cultured from healthy uninfected sinuses. "Normal flora" include ...

It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of ... Nucala for chronic obstructive pulmonary disease or smoker's lungs. The trial met its primary ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

If an oroantral communication is suspected, prompt surgical management is recommended to reduce the likelihood of causing chronic sinus disease.

Pilonidal disease is an acute or chronic infection in the subcutaneous ... This method is also problematic in patients with a pilonidal sinus larger than 4–5 cm and in those who have undergone ...